Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Boehringer Ingelheim, AnGes sign manufacturing agreement for HGF gene therapy product

Johnson & Johnson MedTech India, Karkinos collaborate to upskill healthcare professionals in cancer care

Ruchika Sharma12 Feb 2023 11:30 AM IST

Mumbai: Johnson & Johnson MedTech India has announced a collaboration with Karkinos Healthcare, an end-to-end technology platform, to pursue...

Aurobindo Pharma arm Rajasthan facility gets 9 USFDA observations

Aurobindo Pharma misses Q3 profit view on higher input costs

Ruchika Sharma12 Feb 2023 10:15 AM IST

The company derives about 90 percent of its revenue from exports, with US and Europe being two of its major markets.

Sun Pharma recalls over 34000 bottles of generic medication in US due to failed dissolution testing

Ruchika Sharma11 Feb 2023 2:35 PM IST

New Delhi: Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to...

Solara Active Pharma Sciences Mangalore facility successfully completes USFDA inspection

Laurus Labs gets 2 USFDA observations for Visakhapatnam facility

Ruchika Sharma11 Feb 2023 1:15 PM IST

Telangana: Laurus Labs has announced that the company has received Form 483 with two observations from the US Food and Drug Administration (USFDA)...

Sun Pharma bags USFDA okay for generic lenalidomide capsules

Ruchika Sharma11 Feb 2023 12:30 PM IST

Mumbai: Pharma major, Sun Pharmaceutical Industries Limited, has announced that one of its wholly owned subsidiaries has received final approval from...

GSK gets full USFDA nod for Jemperli to treat recurrent or advanced mismatch repair deficient endometrial cancer

Ruchika Sharma11 Feb 2023 11:30 AM IST

Jemperli is a programmed death receptor-1 (PD-1)-blocking antibody that binds to the PD-1 receptor and blocks its interaction with the PD-1 ligands...

Lupin Launches Dasatinib in US Market in Partnership with Pharmascience

Lupin reports 72 percent decline in consolidated net profit at Rs 153 crore for Q3

Ruchika Sharma11 Feb 2023 9:00 AM IST

New Delhi: Drug maker Lupin has reported 72 percent decline in consolidated net profit at Rs 153 crore for the third quarter ended December 31,...

Natco Pharma Gets USFDA Tentative Approval for Cancer Drug Erdafitinib

Natco Pharma consolidated net profit declines 22 percent at Rs 62 crore in Q3

Ruchika Sharma10 Feb 2023 3:30 PM IST

New Delhi: Natco Pharma has announced that its consolidated net profit declined by 22 percent to Rs 62 crore for the third quarter ended December 31,...

COVID vaccine: NTAGI holds meeting on Covovax inclusion as heterologous booster for adults on CoWin portal

Ruchika Sharma10 Feb 2023 2:54 PM IST

New Delhi: National Technical Advisory Group on Immunisation conducted a meeting on February 8 regarding the inclusion of Covid-19 vaccine Covovax as...

Piramal Pharma reports consolidated net loss of Rs 90 crore in Q3

Ruchika Sharma10 Feb 2023 1:15 PM IST

New Delhi: Piramal Pharma has reported a net loss of Rs 90 crore on a consolidated basis for the third quarter ended December 31, 2022. The...

Serum Institute cervical cancer vaccine CERVAVAC to be available in market this month at Rs 2000 for two doses: Sources

Ruchika Sharma10 Feb 2023 12:15 PM IST

New Delhi: The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of...

Pfizer ropes in Meenakshi Nevatia as MD, Additional Director

Ruchika Sharma10 Feb 2023 11:34 AM IST

S. Sridhar the current India Country President will be stepping down as Managing Director and Member of Board close of business hours on 31st March...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok